Cargando…
Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey
BACKGROUND: Xpert MTB/RIF (“Xpert”) is a molecular test for detection of Mycobacterium tuberculosis (MTB) in sputum. Performance characteristics have been established for its use during passive tuberculosis (TB) case detection in symptomatic TB suspects, but Xpert performance has not been assessed i...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419700/ https://www.ncbi.nlm.nih.gov/pubmed/22905254 http://dx.doi.org/10.1371/journal.pone.0043307 |
_version_ | 1782240762687127552 |
---|---|
author | Dorman, Susan E. Chihota, Violet N. Lewis, James J. Shah, Maunank Clark, David Grant, Alison D. Churchyard, Gavin J. Fielding, Katherine L. |
author_facet | Dorman, Susan E. Chihota, Violet N. Lewis, James J. Shah, Maunank Clark, David Grant, Alison D. Churchyard, Gavin J. Fielding, Katherine L. |
author_sort | Dorman, Susan E. |
collection | PubMed |
description | BACKGROUND: Xpert MTB/RIF (“Xpert”) is a molecular test for detection of Mycobacterium tuberculosis (MTB) in sputum. Performance characteristics have been established for its use during passive tuberculosis (TB) case detection in symptomatic TB suspects, but Xpert performance has not been assessed in other settings. Objectives were to determine Xpert performance and costs in the context of a TB prevalence survey. METHODOLOGY/PRINCIPAL FINDINGS: This was a diagnostic sub-study of a TB prevalence survey conducted in gold mining companies in South Africa. Sputa (one per participant) were tested using smear microscopy, liquid culture (reference comparator), and Xpert. Costs were collected using an ingredients approach and analyzed using a public health program perspective. 6893 participants provided a sputum specimen. 187/6893 (2.7%) were positive for MTB in culture, 144/6893 (2.1%) were positive for MTB by Xpert, and 91/6893 (1.3%) were positive for acid fast bacilli by microsocopy. Sensitivity, specificity, positive predictive value, and negative predictive value for detection of MTB by Xpert were 62.6% (95% confidence interval [CI] 55.2, 69.5), 99.6% (99.4, 99.7), 81.3% (73.9, 87.3), and 98.9 (98.6, 98.8); agreement between Xpert and culture was 98.5% (98.2, 98.8). Sensitivity of microscopy was 17.6% (12.5, 23.9). When individuals with a history of TB treatment were excluded from the analysis, Xpert specificity was 99.8 (99.7, 99.9) and PPV was 90.6 (83.3, 95.4) for detection of MTB. For the testing scenario of 7000 specimens with 2.7% of specimens culture positive for MTB, costs were $165,690 for Xpert and $115,360 for the package of microscopy plus culture. CONCLUSION: In the context of a TB prevalence survey, the Xpert diagnostic yield was substantially higher than that of microscopy yet lower than that of liquid culture. Xpert may be useful as a sole test for TB case detection in prevalence surveys, particularly in settings lacking capacity for liquid culture. |
format | Online Article Text |
id | pubmed-3419700 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-34197002012-08-17 Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey Dorman, Susan E. Chihota, Violet N. Lewis, James J. Shah, Maunank Clark, David Grant, Alison D. Churchyard, Gavin J. Fielding, Katherine L. PLoS One Research Article BACKGROUND: Xpert MTB/RIF (“Xpert”) is a molecular test for detection of Mycobacterium tuberculosis (MTB) in sputum. Performance characteristics have been established for its use during passive tuberculosis (TB) case detection in symptomatic TB suspects, but Xpert performance has not been assessed in other settings. Objectives were to determine Xpert performance and costs in the context of a TB prevalence survey. METHODOLOGY/PRINCIPAL FINDINGS: This was a diagnostic sub-study of a TB prevalence survey conducted in gold mining companies in South Africa. Sputa (one per participant) were tested using smear microscopy, liquid culture (reference comparator), and Xpert. Costs were collected using an ingredients approach and analyzed using a public health program perspective. 6893 participants provided a sputum specimen. 187/6893 (2.7%) were positive for MTB in culture, 144/6893 (2.1%) were positive for MTB by Xpert, and 91/6893 (1.3%) were positive for acid fast bacilli by microsocopy. Sensitivity, specificity, positive predictive value, and negative predictive value for detection of MTB by Xpert were 62.6% (95% confidence interval [CI] 55.2, 69.5), 99.6% (99.4, 99.7), 81.3% (73.9, 87.3), and 98.9 (98.6, 98.8); agreement between Xpert and culture was 98.5% (98.2, 98.8). Sensitivity of microscopy was 17.6% (12.5, 23.9). When individuals with a history of TB treatment were excluded from the analysis, Xpert specificity was 99.8 (99.7, 99.9) and PPV was 90.6 (83.3, 95.4) for detection of MTB. For the testing scenario of 7000 specimens with 2.7% of specimens culture positive for MTB, costs were $165,690 for Xpert and $115,360 for the package of microscopy plus culture. CONCLUSION: In the context of a TB prevalence survey, the Xpert diagnostic yield was substantially higher than that of microscopy yet lower than that of liquid culture. Xpert may be useful as a sole test for TB case detection in prevalence surveys, particularly in settings lacking capacity for liquid culture. Public Library of Science 2012-08-15 /pmc/articles/PMC3419700/ /pubmed/22905254 http://dx.doi.org/10.1371/journal.pone.0043307 Text en © 2012 Dorman et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Dorman, Susan E. Chihota, Violet N. Lewis, James J. Shah, Maunank Clark, David Grant, Alison D. Churchyard, Gavin J. Fielding, Katherine L. Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey |
title | Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey |
title_full | Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey |
title_fullStr | Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey |
title_full_unstemmed | Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey |
title_short | Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey |
title_sort | performance characteristics of the cepheid xpert mtb/rif test in a tuberculosis prevalence survey |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419700/ https://www.ncbi.nlm.nih.gov/pubmed/22905254 http://dx.doi.org/10.1371/journal.pone.0043307 |
work_keys_str_mv | AT dormansusane performancecharacteristicsofthecepheidxpertmtbriftestinatuberculosisprevalencesurvey AT chihotavioletn performancecharacteristicsofthecepheidxpertmtbriftestinatuberculosisprevalencesurvey AT lewisjamesj performancecharacteristicsofthecepheidxpertmtbriftestinatuberculosisprevalencesurvey AT shahmaunank performancecharacteristicsofthecepheidxpertmtbriftestinatuberculosisprevalencesurvey AT clarkdavid performancecharacteristicsofthecepheidxpertmtbriftestinatuberculosisprevalencesurvey AT grantalisond performancecharacteristicsofthecepheidxpertmtbriftestinatuberculosisprevalencesurvey AT churchyardgavinj performancecharacteristicsofthecepheidxpertmtbriftestinatuberculosisprevalencesurvey AT fieldingkatherinel performancecharacteristicsofthecepheidxpertmtbriftestinatuberculosisprevalencesurvey |